Title:
N末端が修飾されたFGF21化合物
Document Type and Number:
Japanese Patent JP2013532644
Kind Code:
A
Abstract:
Analogs of FGF21 carrying a modifying, substituted ethylene or benzyl group can be used for treatment or prevention of diabetes, dyslipidemia, obesity, cardiovascular diseases, metabolic syndrome, and/or Non Alcoholic Fatty Liver Disease (NAFLD).
More Like This:
Inventors:
Tina Muller Tagmoses
Patrick William Gallibai
Shujia Chan
Henning Touyasun
Peter Kresten Nilsen
Biagite Andersen
Jish Wan
Christian Sass Baku-Jensen
Hereto Fabricius Verdike
Patrick William Gallibai
Shujia Chan
Henning Touyasun
Peter Kresten Nilsen
Biagite Andersen
Jish Wan
Christian Sass Baku-Jensen
Hereto Fabricius Verdike
Application Number:
JP2013520107A
Publication Date:
August 19, 2013
Filing Date:
July 18, 2011
Export Citation:
Assignee:
Novo Nordisk Ar/S
International Classes:
C07K14/50; A61K38/22; A61P1/16; A61P3/04; A61P3/06; A61P3/10; A61P9/00; A61P43/00; C12N15/09
Domestic Patent References:
| JP2012515747A | 2012-07-12 | |||
| JP2008518601A | 2008-06-05 | |||
| JP2010523084A | 2010-07-15 | |||
| JP2007505840A | 2007-03-15 | |||
| JP2007537981A | 2007-12-27 | |||
| JP2008507477A | 2008-03-13 | |||
| JP2007535306A | 2007-12-06 | |||
| JP2008506635A | 2008-03-06 | |||
| JP2012515747A | 2012-07-12 | |||
| JP2008518601A | 2008-06-05 | |||
| JP2010523084A | 2010-07-15 | |||
| JP2007505840A | 2007-03-15 | |||
| JP2007537981A | 2007-12-27 | |||
| JP2008507477A | 2008-03-13 | |||
| JP2007535306A | 2007-12-06 | |||
| JP2008506635A | 2008-03-06 |
Attorney, Agent or Firm:
Yasuhiko Murayama
Masatake Shiga
Takashi Watanabe
Shinya Mitsuhiro
Masatake Shiga
Takashi Watanabe
Shinya Mitsuhiro